Last quarter (Q1 2023), Xvivo Perfusion AB's total revenue was kr140.62M, an increase of 51.76% from the same quarter last year. In Q1, Xvivo Perfusion AB's net income was kr14.18M. See Xvivo Perfusion AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	kr 463.25M	kr 415.29M	kr 258.39M	kr 179.86M	kr 220.84M	kr 187.87M
Cost of Revenue	kr 126.70M	kr 118.34M	kr 70.11M	kr 50.13M	kr 58.02M	kr 51.91M
Gross Profit	kr 336.55M	kr 296.96M	kr 188.28M	kr 129.73M	kr 162.81M	kr 135.95M
Operating Expense	kr 325.51M	kr 292.50M	kr 207.02M	kr 173.92M	kr 158.84M	kr 122.47M
Operating Income	kr 11.04M	kr 4.46M	kr -18.74M	kr -44.19M	kr 3.97M	kr 13.48M
Net Non Operating Interest Income Expense	kr 4.82M	kr 1.03M	kr 19.47M	kr -482.00K	kr 120.00K	kr 235.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	kr 32.69M	kr 22.31M	kr 6.67M	kr -57.26M	kr 5.29M	kr 17.50M
Tax Provision	kr 4.85M	kr 3.89M	kr -1.49M	kr -13.53M	kr 351.00K	kr 4.81M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr 27.84M	kr 18.43M	kr 8.15M	kr -43.73M	kr 4.94M	kr 12.69M
Basic EPS	kr 0.94	kr 0.62	kr 0.28	kr -1.61	kr 0.19	kr 0.48
Diluted EPS	kr 0.94	kr 0.62	kr 0.28	kr -1.61	kr 0.18	kr 0.48
Basic Average Shares	kr 118.44M	kr 29.53M	kr 28.85M	kr 27.17M	kr 26.52M	kr 26.30M
Diluted Average Shares	kr 118.44M	kr 29.53M	kr 28.94M	kr 27.35M	kr 26.80M	kr 26.30M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 452.21M	kr 410.84M	kr 277.13M	kr 224.05M	kr 216.87M	kr 174.39M
Net Income From Continuing And Discontinued Operation	kr 27.84M	kr 18.43M	kr 8.15M	kr -43.73M	kr 4.94M	kr 12.69M
Normalized Income	kr 27.84M	kr 18.64M	kr 8.18M	kr -43.73M	kr 4.99M	kr 12.69M
Interest Expense	-	kr 605.00K	kr 276.00K	kr 361.00K	kr 285.00K	kr 128.00K
EBIT	kr 29.50M	kr 22.92M	kr 6.94M	kr -56.90M	kr 5.58M	kr 17.63M
EBITDA	kr 29.50M	kr 65.09M	kr 39.20M	kr -26.86M	kr 30.43M	kr 34.55M

Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing